Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

The New Cholesterol Lowering Drugs Epitomize The Drug Pricing Battles
Forbes
Fri, 08/28/15 - 08:19 am
Tags:
drug pricing, Repatha, Praluent, Sanofi, Regeneron, Amgen, PCSK9 inhibitors
How Big Biotech Spents It’s Money
Barron's
Fri, 08/21/15 - 05:23 pm
Tags:
biotech, Amgen, Biogen, Regeneron, Celgene, Gilead, Alexion
Payers Set To Play Hardball On PCSK9 Pricing
Investors.com
Fri, 08/14/15 - 11:22 am
Tags:
payer negotiation, drug pricing, PCSK9 inhibitors, Sanofi, Regeneron, Amgen, hepatitis C, Express Scripts
CVS to adopt 'wait and see' approach on PCSK9 cholesterol meds
BioPharma Dive
Mon, 08/10/15 - 10:53 am
Tags:
CVS, PCSK9 inhibitors, formulary, Sanofi, Regeneron, Praluent, Amgen, Repatha
Will Regeneron's New Drug Break The Bank?
Motley Fool
Wed, 08/5/15 - 09:28 am
Tags:
Regeneron, Praluent, drug pricing, Sanofi
Eylea erodes Lucentis, Avastin market share
Medical Marketing and Media
Tue, 08/4/15 - 06:10 pm
Tags:
Eylea, Lucentis, Avastin, Regeneron, Roche/Genentech
Regeneron Tops Q2 Estimates, Shares Surge
Benzinga
Tue, 08/4/15 - 08:23 am
Tags:
Regeneron, earnings
Sanofi draws a $14,600 line in the sand for Praluent payer fight
Fierce Pharma Marketing
Tue, 07/28/15 - 10:22 am
Tags:
Sanofi, Praluent, Repatha, Amgen, Regeneron, drug pricing, PCSK9 inhibitors
Sanofi links with Regeneron in $2.2 bln cancer drug push
Yahoo/Reuters
Tue, 07/28/15 - 10:03 am
Tags:
Sanofi, Regeneron, cancer immunotherapy, R&D
Why Regeneron’s Approval is Bad News For Esperion Therapeutics
Barron's
Mon, 07/27/15 - 01:55 pm
Tags:
Regeneron, Esperion Therapeutics, Sanofi, Praluent, Amgen, Repatha, ETC-1002
Docs are Excited About Prescribing Those New Cholesterol Drugs: Survey
WSJ Pharmalot
Fri, 07/24/15 - 03:47 pm
Tags:
physicians, PCSK9 inhibitors, Praluent, Repatha, Amgen, Sanofi, Regeneron
Sanofi's big new cholesterol drug wins European green light
Yahoo/Reuters
Fri, 07/24/15 - 10:05 am
Tags:
Praluent, Sanofi, Regeneron, Europe, PCSK9 inhibitors, Amgen, Repatha
Praluent's FDA review looms, but questions persist
Medical Marketing and Media
Wed, 07/22/15 - 09:45 pm
Tags:
Praluent, FDA, PCSK9 inhibitors, Sanofi, Regeneron
2015’s Top 6 Big Pharma Headlines Thus Far
Motley Fool
Wed, 07/22/15 - 08:36 am
Tags:
Pfizer, M&A, Hospira, AbbVie, Pharmacyclics, PCSK9 inhibitors, Amgen, Sanofi, Regeneron, Express Scripts, Bristol-Myers Squibb, Opdivo
Why July Will Be an Exciting Month for Regeneron Pharmaceuticals
Motley Fool
Sun, 07/12/15 - 09:41 am
Tags:
Regeneron, FDA, Sanofi, Praluent
Sanofi, Regeneron say Japan study shows Praluent drug lowers cholesterol
Yahoo/Reuters
Thu, 07/9/15 - 10:14 am
Tags:
Sanofi, Regeneron, Japan, Praluent
Why Praluent Could Be Blockbuster For Regeneron
Seeking Alpha
Tue, 07/7/15 - 11:41 am
Tags:
Praluent, Regeneron
What Is Beyond Vision-Loss Blockbuster For Regeneron?
Investors.com
Wed, 07/1/15 - 10:49 pm
Tags:
Regeneron, Eylea, Praluent
Is Amgen About to Enter a Battle Over Billions?
Investopedia
Tue, 06/16/15 - 09:10 am
Tags:
Amgen, Sanofi, Regeneron, Repatha, Praluent, PCSK9 inhibitors
Survey shows doctors ready for PCSK9s
Medical Marketing and Media
Mon, 06/15/15 - 04:24 pm
Tags:
physicians, PCSK9 inhibitors, Sanofi, Regeneron, Praluent, Amgen, Repatha

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.